Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$1.12 - $1.49 $105,730 - $140,658
-94,402 Reduced 42.79%
126,211 $150,000
Q1 2023

May 15, 2023

BUY
$1.19 - $2.19 $262,529 - $483,142
220,613 New
220,613 $330,000
Q2 2022

Aug 15, 2022

BUY
$1.13 - $3.69 $870,928 - $2.84 Million
770,733 Added 616.16%
895,819 $1.33 Million
Q1 2022

May 16, 2022

BUY
$2.85 - $3.73 $74,789 - $97,882
26,242 Added 26.55%
125,086 $412,000
Q2 2021

Aug 13, 2021

BUY
$4.26 - $6.5 $421,075 - $642,486
98,844 New
98,844 $433,000
Q4 2020

Feb 16, 2021

SELL
$4.04 - $5.31 $1.31 Million - $1.72 Million
-323,968 Closed
0 $0
Q3 2020

Nov 16, 2020

BUY
$3.64 - $7.76 $292,732 - $624,066
80,421 Added 33.02%
323,968 $1.36 Million
Q2 2020

Aug 13, 2020

SELL
$4.78 - $8.26 $1.51 Million - $2.6 Million
-314,861 Reduced 56.39%
243,547 $1.69 Million
Q1 2020

May 15, 2020

BUY
$4.0 - $21.53 $2.12 Million - $11.4 Million
530,350 Added 1890.19%
558,408 $2.23 Million
Q4 2019

Feb 14, 2020

BUY
$13.94 - $24.12 $391,128 - $676,758
28,058 New
28,058 $602,000

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $177M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Marshall Wace, LLP Portfolio

Follow Marshall Wace, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.